Efficacy and safety of combination therapy with vildagliptin and metformin versus metformin uptitration in Chinese patients with type 2 diabetes inadequately controlled with metformin monotherapy: a randomized, open-label, prospective study (VISION)

L.-N. Ji; C.-Y. Pan; J.-M. Lu; H. Li; D.-L. Zhu; Q. Li; Q.-F. Li; Y.-D. Peng; H.-M. Tian; C. Yao; Z.-G. Zhao; L. Wang; B.-H. Wang;

doi:10.1111/dom.12667

Efficacy and safety of combination therapy with vildagliptin and metformin versus metformin uptitration in Chinese patients with type 2 diabetes inadequately controlled with metformin monotherapy: a randomized, open-label, prospective study (VISION)

Diabetes Obesity and Metabolism ◽

10.1111/dom.12667 ◽

2016 ◽

Vol 18 (8) ◽

pp. 775-782 ◽

Cited By ~ 9

Author(s):

L.-N. Ji ◽

C.-Y. Pan ◽

J.-M. Lu ◽

H. Li ◽

D.-L. Zhu ◽

...

Keyword(s):

Type 2 Diabetes ◽

Combination Therapy ◽

Prospective Study ◽

Chinese Patients ◽

Efficacy And Safety ◽

Open Label ◽

Metformin Monotherapy

Download Full-text

Efficacy and safety of saxagliptin compared with acarbose in Chinese patients with type 2 diabetes mellitus uncontrolled on metformin monotherapy: Results of a Phase IV open-label randomized controlled study (the SMART study)

Diabetes Obesity and Metabolism ◽

10.1111/dom.12942 ◽

2017 ◽

Vol 19 (11) ◽

pp. 1513-1520 ◽

Cited By ~ 9

Author(s):

Jin Du ◽

Li Liang ◽

Hui Fang ◽

Fengmei Xu ◽

Wei Li ◽

...

Keyword(s):

Diabetes Mellitus ◽

Type 2 Diabetes ◽

Chinese Patients ◽

Controlled Study ◽

Efficacy And Safety ◽

Open Label ◽

Randomized Controlled ◽

Smart Study ◽

Metformin Monotherapy

Download Full-text

Efficacy and safety of liraglutide versus sitagliptin, both in combination with metformin, in Chinese patients with type 2 diabetes: a 26‐week, open‐label, randomized, active comparator clinical trial

Diabetes Obesity and Metabolism ◽

10.1111/dom.12674 ◽

2016 ◽

Vol 18 (8) ◽

pp. 803-811 ◽

Cited By ~ 14

Author(s):

L. Zang ◽

Y. Liu ◽

J. Geng ◽

Y. Luo ◽

F. Bian ◽

...

Keyword(s):

Type 2 Diabetes ◽

Clinical Trial ◽

Chinese Patients ◽

Efficacy And Safety ◽

Open Label ◽

Active Comparator

Download Full-text

Efficacy and safety of biphasic insulin aspart 30 combined with pioglitazone in type 2 diabetes poorly controlled on glibenclamide (glyburide) monotherapy or combination therapy: An 18-week, randomized, open-label study

Clinical Therapeutics ◽

10.1016/j.clinthera.2005.09.001 ◽

2005 ◽

Vol 27 (9) ◽

pp. 1432-1443 ◽

Cited By ~ 15

Author(s):

Itamar Raz ◽

Stephen Stranks ◽

Robert Filipczak ◽

Pankaj Joshi ◽

Benedikte Lertoft ◽

...

Keyword(s):

Type 2 Diabetes ◽

Combination Therapy ◽

Insulin Aspart ◽

Efficacy And Safety ◽

Open Label ◽

Open Label Study ◽

Label Study ◽

Biphasic Insulin ◽

Biphasic Insulin Aspart 30

Download Full-text

Efficacy and safety of nateglinide plus sitagliptin combination therapy in type 2 diabetes patients inadequately controlled by sitagliptin monotherapy: a phase 3, multicenter, open-label, long-term study

Diabetology International ◽

10.1007/s13340-017-0341-z ◽

2018 ◽

Vol 9 (3) ◽

pp. 168-178

Author(s):

Takahisa Hirose ◽

Chihiro Saitoh ◽

Ichiro Oikawa ◽

Nobuo Kondo

Keyword(s):

Type 2 Diabetes ◽

Combination Therapy ◽

Efficacy And Safety ◽

Open Label ◽

Term Study ◽

Phase 3 ◽

Long Term Study ◽

Diabetes Patients

Download Full-text

Study Protocol for a Prospective, Multicenter, Randomized, Open-Label, Parallel-Group Clinical Trial Comparing the Efficacy and Safety of a Needle-Free Insulin Injector and a Conventional Insulin Pen in Controlling Blood Glucose Concentrations in Chinese Patients with Type 2 Diabetes Mellitus (The FREE Study)

Advances in Therapy ◽

10.1007/s12325-019-00951-4 ◽

2019 ◽

Vol 36 (6) ◽

pp. 1485-1496 ◽

Cited By ~ 1

Author(s):

LiNong Ji ◽

LiMing Chen ◽

YanGang Wang ◽

ZhongShu Ma ◽

XingWu Ran ◽

...

Keyword(s):

Diabetes Mellitus ◽

Type 2 Diabetes ◽

Clinical Trial ◽

Chinese Patients ◽

Efficacy And Safety ◽

Open Label ◽

Parallel Group ◽

Free Insulin ◽

Blood Glucose Concentrations

Download Full-text

The efficacy and safety of teneligliptin added to ongoing metformin monotherapy in patients with type 2 diabetes: a randomized study with open label extension

Expert Opinion on Pharmacotherapy ◽

10.1080/14656566.2016.1190334 ◽

2016 ◽

Vol 17 (10) ◽

pp. 1309-1316 ◽

Cited By ~ 10

Author(s):

Andrew Bryson ◽

Paul E Jennings ◽

Laszlo Deak ◽

Fraga S Paveliu ◽

Matt Lawson

Keyword(s):

Type 2 Diabetes ◽

Randomized Study ◽

Efficacy And Safety ◽

Open Label ◽

Metformin Monotherapy ◽

Open Label Extension

Download Full-text

A randomized controlled trial of the efficacy and safety of twice-daily saxagliptin plus metformin combination therapy in patients with type 2 diabetes and inadequate glycemic control on metformin monotherapy

BMC Endocrine Disorders ◽

10.1186/1472-6823-14-17 ◽

2014 ◽

Vol 14 (1) ◽

Cited By ~ 15

Author(s):

Judith L White ◽

Patricia Buchanan ◽

Jia Li ◽

Robert Frederich

Keyword(s):

Type 2 Diabetes ◽

Randomized Controlled Trial ◽

Glycemic Control ◽

Combination Therapy ◽

Controlled Trial ◽

Efficacy And Safety ◽

Randomized Controlled ◽

Metformin Monotherapy ◽

Inadequate Glycemic Control

Download Full-text

Efficacy and safety of combination therapy with vildagliptin and metformin versus metformin up-titration in Chinese patients with type 2 diabetes mellitus: study design and rationale of the vision study

Cardiovascular Diabetology ◽

10.1186/1475-2840-12-118 ◽

2013 ◽

Vol 12 (1) ◽

pp. 118 ◽

Cited By ~ 5

Author(s):

Li-Nong Ji ◽

Chang-Yu Pan ◽

Ju-Ming Lu ◽

Hong Li ◽

Qiang Li ◽

...

Keyword(s):

Diabetes Mellitus ◽

Type 2 Diabetes ◽

Type 2 Diabetes Mellitus ◽

Combination Therapy ◽

Study Design ◽

Chinese Patients ◽

Efficacy And Safety

Download Full-text

Comparative evaluation of efficacy and safety of combination of metformin-vidagliptin versus metfromin-glimepiride in most frequently used doses in patients of type 2 diabetes mellitus with inadequately controlled metformin monotherapy-A randomised open label study

Perspectives in Clinical Research ◽

10.4103/2229-3485.159942 ◽

2015 ◽

Vol 6 (3) ◽

pp. 163

Author(s):

Vijay Khajuria ◽

VishalR Tandon ◽

Annil Mahajan ◽

ZahidH Gillani ◽

Shallini Gupta

Keyword(s):

Diabetes Mellitus ◽

Type 2 Diabetes ◽

Type 2 Diabetes Mellitus ◽

Comparative Evaluation ◽

Efficacy And Safety ◽

Open Label ◽

Open Label Study ◽

Label Study ◽

Metformin Monotherapy

Download Full-text

Efficacy and safety of miglitol- or repaglinide-based combination therapy with alogliptin in drug-naïve patients with type 2 diabetes: An open-label, single-center, parallel, randomized control pilot study

Journal of Nippon Medical School ◽

10.1272/jnms.jnms.2021_88-205 ◽

2020 ◽

Author(s):

Fumitaka Okajima ◽

Hitoshi Sugihara ◽

Naoya Emoto

Keyword(s):

Type 2 Diabetes ◽

Pilot Study ◽

Combination Therapy ◽

Efficacy And Safety ◽

Single Center ◽

Open Label ◽

Drug Naïve ◽

Randomized Control

Download Full-text